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Abstract  
 
Nontuberculous mycobacteria (NTM) are a large, diverse group of environmental 
organisms. They cause a variety of diseases in humans, notably severe, protracted lung 
disease in patients with underlying lung disorders. In Japan, Mycobacterium avium 
complex (MAC) accounts for approximately 70% of NTM. Rheumatoid arthritis (RA) has 
many pulmonary manifestations, including bronchial abnormalities that can develop 
into MAC pulmonary disease (PD). MAC-PD can be lethal in patients receiving tumor 
necrosis factor-alpha blockers despite administration of antibiotics. Diagnosis of 
MAC-PD is often difficult, because MAC is an environmental organism. In this study, 
we investigated the usefulness of serodiagnosis of MAC-PD in RA patients by using an 
enzyme immunoassay (EIA) kit that detects anti-glycopeptidolipid (GPL) core antigen 
IgA antibodies. Antibody levels were measured in 63 patients with RA: 14 with 
MAC-PD plus 3 cultured NTM other than MAC, 16 with pulmonary abnormalities 
characterizing NTM but undetected in sputum culture, and 30 control subjects. RA 
patients with MAC-PD showed significantly higher antibody levels than controls (p = 
0.02). The cutoff point was set at 0.7 IU/l, making the sensitivity and specificity of the 
antibody in MAC-PD and control patients 43% and 100%, respectively. The EIA kit is 
useful for diagnosis of MAC-PD in RA patients because of its high specificity. This test is 
an easier and less invasive form of examination and could therefore replace 
bronchoscopy as the main diagnostic procedure for RA patients with MAC-PD. 
 
 
